AIRLINK 76.94 Decreased By ▼ -0.90 (-1.16%)
BOP 4.91 Increased By ▲ 0.04 (0.82%)
CNERGY 4.25 Decreased By ▼ -0.03 (-0.7%)
DFML 44.79 Decreased By ▼ -0.21 (-0.47%)
DGKC 85.45 Decreased By ▼ -0.52 (-0.6%)
FCCL 22.31 Decreased By ▼ -0.14 (-0.62%)
FFBL 31.59 Decreased By ▼ -0.41 (-1.28%)
FFL 9.41 Decreased By ▼ -0.09 (-0.95%)
GGL 10.03 Decreased By ▼ -0.06 (-0.59%)
HASCOL 6.59 Increased By ▲ 0.04 (0.61%)
HBL 109.00 Decreased By ▼ -3.00 (-2.68%)
HUBC 140.24 Decreased By ▼ -0.96 (-0.68%)
HUMNL 10.66 Decreased By ▼ -0.31 (-2.83%)
KEL 4.89 Increased By ▲ 0.04 (0.82%)
KOSM 4.33 Decreased By ▼ -0.02 (-0.46%)
MLCF 37.80 Decreased By ▼ -0.45 (-1.18%)
OGDC 128.38 Decreased By ▼ -0.51 (-0.4%)
PAEL 25.21 Decreased By ▼ -0.30 (-1.18%)
PIBTL 6.34 Decreased By ▼ -0.02 (-0.31%)
PPL 117.00 Decreased By ▼ -0.50 (-0.43%)
PRL 25.89 Increased By ▲ 0.09 (0.35%)
PTC 13.81 Increased By ▲ 0.07 (0.51%)
SEARL 56.50 Decreased By ▼ -0.59 (-1.03%)
SNGP 63.99 Decreased By ▼ -1.00 (-1.54%)
SSGC 9.99 Decreased By ▼ -0.01 (-0.1%)
TELE 8.11 Decreased By ▼ -0.01 (-0.12%)
TPLP 10.24 Decreased By ▼ -0.11 (-1.06%)
TRG 64.40 Decreased By ▼ -0.84 (-1.29%)
UNITY 26.77 Decreased By ▼ -0.08 (-0.3%)
WTL 1.33 Decreased By ▼ -0.01 (-0.75%)
BR100 7,787 Decreased By -47.3 (-0.6%)
BR30 25,012 Decreased By -232.8 (-0.92%)
KSE100 74,256 Decreased By -410.6 (-0.55%)
KSE30 23,798 Decreased By -121 (-0.51%)

HYDERABAD, (India): The US Food and Drug Administration (FDA) is gathering information on products of Indian spice makers MDH and Everest after Hong Kong halted sales of some of their products for allegedly containing high levels of a cancer-causing pesticide.

“The FDA is aware of the reports and is gathering additional information about the situation,” an FDA spokesperson told Reuters on Friday.

Hong Kong this month suspended sales of three MDH spice blends and an Everest spice mix for fish curries. Singapore ordered a recall of the Everest spice mix as well, saying it contains high levels of ethylene oxide, which is unfit for human consumption and a cancer risk with long exposure.

Reuters is the first to report the US FDA’s review of alleged contamination of Indian spice products.

MDH and Everest did not immediately respond to Reuters requests for comment on this matter.

Everest has previously said its spices are safe for consumption. MDH has not responded to queries about its products so far.

Comments

Comments are closed.